Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Kilitch Drugs (india) Limited
Kilitch Drugs (india) Limited has been active since 1992, providing more than 34 years of industry experience. Kilitch Drugs (india) Limited is registered with CIN L24239MH1992PLC066718 (reg. no. 66718). This entity is incorporated as company limited by shares. Authorized share capital stands at ₹25.00 crore. Kilitch Drugs (india) Limited’s paid-up capital stands at ₹16.08 crore.
The company’s main operations are related to manufacture of other chemical products. It is registered in Mumbai. The company is incorporated with the address C 301/2 Midc Ttc Indl Area Pawane, Thane, Thane, Maharashtra, India, 400705. The firm continues to be in active status. Kilitch Drugs (india) Limited holds the LEI code 335800NMETDAZKVPII87. The firm’s registered email for correspondence is pushpanyoupane@kilitch.com. The leadership team includes Sunil Sureshji Jain (CFO).
Company Overview
- CIN
- Date of Incorporation
- 11/05/1992
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹25,00,00,000.00
- Paid up Capital
- ₹16,08,23,000.00
- Activity
- Manufacture of other chemical products
- pushpanyoupane@kilitch.com
- PAN
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Net PPE | ₹18,871.51L | ₹9,281.89L | ₹4,812.04L | ₹4,735.78L |
| Net Debt | ₹7,296.40L | ₹3,967.51L | ₹1,273.65L | ₹239.95L |
| Goodwill | ₹1,769.35L | ₹1,853.60L | ₹1,937.85L | ₹2,022.11L |
| Gross PPE | ₹22,081.22L | ₹12,231.22L | ₹7,551.50L | ₹7,235.38L |
| Inventory | ₹1,198.84L | ₹2,157.83L | ₹558.18L | ₹240.70L |
| Total Debt | ₹8,870.90L | ₹4,942.40L | ₹3,164.65L | ₹2,219.35L |
| Common Stock | ₹3,496.16L | ₹1,608.23L | ₹1,608.23L | ₹1,558.23L |
| Current Debt | ₹3,010.55L | ₹2,165.36L | ₹3,164.65L | ₹2,219.35L |
| Share Issued | ₹349.62L | ₹328.68L | ₹328.68L | ₹318.46L |
| Total Assets | ₹45,774.92L | ₹31,278.38L | ₹24,006.16L | ₹21,952.13L |
| Capital Stock | ₹3,496.16L | ₹1,608.23L | ₹1,608.23L | ₹1,558.23L |
| Long Term Debt | ₹5,860.35L | ₹2,777.04L | ₹0.00L | ₹0.00L |
| Current Assets | ₹22,219.51L | ₹17,391.65L | ₹14,599.28L | ₹12,640.31L |
| Prepaid Assets | ₹2,125.79L | ₹820.19L | ₹808.24L | ₹1,051.09L |
| Working Capital | ₹10,059.59L | ₹8,960.64L | ₹8,177.69L | ₹5,753.00L |
| Invested Capital | ₹36,836.23L | ₹25,175.31L | ₹20,793.77L | ₹17,379.07L |
| Other Properties | ₹435.46L | ₹411.29L | ₹370.34L | ₹352.85L |
| Retained Earnings | ₹14,109.97L | ₹11,093.33L | ₹8,423.27L | ₹6,963.13L |
| Common Stock Equity | ₹27,965.33L | ₹20,232.91L | ₹17,629.12L | ₹15,159.72L |
| Net Tangible Assets | ₹26,169.57L | ₹18,344.16L | ₹15,646.84L | ₹13,111.28L |
| Tangible Book Value | ₹26,169.57L | ₹18,344.16L | ₹15,646.84L | ₹13,111.28L |
| Current Liabilities | ₹12,159.92L | ₹8,431.01L | ₹6,421.59L | ₹6,887.31L |
| Long Term Provisions | ₹67.94L | ₹24.53L | ₹17.24L | ₹6.83L |
| Stockholders Equity | ₹27,965.33L | ₹20,232.91L | ₹17,629.12L | ₹15,159.72L |
| Other Equity Interest | ₹35.39L | ₹35.43L | ₹35.44L | ₹535.43L |
| Total Capitalization | ₹33,825.68L | ₹23,009.95L | ₹17,629.12L | ₹15,159.72L |
| Ordinary Shares Number | ₹349.62L | ₹328.68L | ₹328.68L | ₹318.46L |
| Other Intangible Assets | ₹26.41L | ₹35.15L | ₹44.43L | ₹26.33L |
| Other Non Current Assets | -₹0.01L | -₹0.02L | -₹0.02L | ₹0.02L |
| Total Non Current Assets | ₹23,555.41L | ₹13,886.73L | ₹9,406.88L | ₹9,311.82L |
| Cash And Cash Equivalents | ₹1,574.50L | ₹974.89L | ₹1,891.00L | ₹1,979.40L |
| Construction In Progress | ₹14,001.93L | ₹4,729.45L | ₹596.50L | ₹361.92L |
| Accumulated Depreciation | -₹3,209.71L | -₹2,949.33L | -₹2,739.46L | -₹2,499.60L |
| Additional Paid In Capital | ₹7,653.31L | ₹4,668.38L | ₹4,668.38L | ₹3,832.63L |
| Other Short Term Investments | ₹5,296.53L | ₹4,956.50L | ₹5,010.92L | ₹3,933.07L |
| Machinery Furniture Equipment | ₹6,022.74L | ₹5,805.44L | ₹5,316.59L | ₹5,259.06L |
| Goodwill And Other Intangible Assets | ₹1,795.76L | ₹1,888.75L | ₹1,982.28L | ₹2,048.44L |
| Total Equity Gross Minority Interest | ₹27,686.71L | ₹20,045.80L | ₹17,567.33L | ₹15,057.99L |
| Total Liabilities Net Minority Interest | ₹18,088.21L | ₹11,232.58L | ₹6,438.83L | ₹6,894.14L |
| Current Debt And Capital Lease Obligation | ₹3,010.55L | ₹2,165.36L | ₹3,164.65L | ₹2,219.35L |
| Long Term Debt And Capital Lease Obligation | ₹5,860.35L | ₹2,777.04L | ₹0.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹6,871.03L | ₹5,931.39L | ₹6,901.92L | ₹5,912.47L |
| Total Non Current Liabilities Net Minority Interest | ₹5,928.29L | ₹2,801.57L | ₹17.24L | ₹6.83L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | -₹7,554.98L | -₹2,933.11L | -₹798.54L | -₹122.61L | ₹0.00L |
| Changes In Cash | ₹597.34L | -₹916.13L | -₹88.45L | ₹978.45L | ₹0.00L |
| End Cash Position | ₹1,577.40L | ₹980.05L | ₹1,896.18L | ₹1,984.60L | ₹0.00L |
| Financing Cash Flow | ₹8,245.25L | ₹1,324.33L | ₹880.67L | -₹71.63L | ₹0.00L |
| Investing Cash Flow | -₹10,043.67L | -₹3,994.69L | -₹815.62L | ₹791.50L | ₹0.00L |
| Operating Cash Flow | ₹2,395.76L | ₹1,754.23L | -₹153.50L | ₹258.58L | ₹0.00L |
| Capital Expenditure | -₹9,950.74L | -₹4,687.34L | -₹645.04L | -₹381.19L | ₹0.00L |
| Beginning Cash Position | ₹980.06L | ₹1,896.18L | ₹1,984.60L | ₹1,006.15L | ₹0.00L |
| Issuance Of Capital Stock | ₹4,872.82L | ₹0.00L | ₹385.75L | ₹250.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| EBIT | ₹4,421.52L | ₹3,951.55L | ₹2,528.39L | ₹1,693.32L |
| EBITDA | ₹4,783.83L | ₹4,262.57L | ₹2,863.35L | ₹2,048.38L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹3,016.64L | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹10,634.99L | ₹9,048.72L | ₹7,313.82L | ₹6,172.34L |
| Pretax Income | ₹3,865.44L | ₹3,447.42L | ₹1,935.45L | ₹1,201.43L |
| Tax Provision | ₹915.41L | ₹953.41L | ₹577.93L | ₹373.16L |
| Total Revenue | ₹23,534.93L | ₹19,723.98L | ₹15,360.62L | ₹13,885.82L |
| Cost Of Revenue | ₹12,899.94L | ₹10,675.26L | ₹8,046.80L | ₹7,713.48L |
| Total Expenses | ₹20,119.24L | ₹16,860.55L | ₹13,252.29L | ₹12,450.75L |
| Interest Income | ₹51.25L | ₹359.45L | ₹40.79L | ₹30.17L |
| Interest Expense | ₹556.08L | ₹504.13L | ₹592.94L | ₹491.89L |
| Operating Income | ₹3,415.69L | ₹2,863.43L | ₹2,108.33L | ₹1,435.07L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹4,421.58L | ₹3,866.58L | ₹2,724.50L | ₹1,966.56L |
| Normalized Income | ₹2,740.18L | ₹2,383.58L | ₹1,362.75L | ₹988.40L |
| Operating Expense | ₹7,219.30L | ₹6,185.29L | ₹5,205.49L | ₹4,737.27L |
| Operating Revenue | ₹23,534.93L | ₹19,723.98L | ₹15,360.62L | ₹13,885.82L |
| Net Interest Income | -₹578.11L | -₹172.57L | -₹562.85L | -₹478.12L |
| Total Unusual Items | ₹362.25L | ₹395.99L | ₹138.85L | ₹81.82L |
| Basic Average Shares | ₹338.43L | ₹328.67L | ₹325.55L | ₹318.45L |
| Diluted Average Shares | ₹338.43L | ₹328.67L | ₹325.55L | ₹318.45L |
| Total Other Finance Cost | ₹73.28L | ₹27.89L | ₹10.70L | ₹16.40L |
| Other Operating Expenses | ₹4,288.24L | ₹3,887.60L | ₹3,014.76L | ₹2,741.49L |
| Reconciled Depreciation | ₹362.31L | ₹311.02L | ₹334.96L | ₹355.06L |
| Reconciled Cost Of Revenue | ₹12,899.94L | ₹10,675.26L | ₹8,046.80L | ₹7,713.48L |
| Rent Expense Supplemental | ₹119.19L | ₹111.80L | ₹139.15L | ₹37.73L |
| Tax Effect Of Unusual Items | ₹85.79L | ₹109.51L | ₹41.46L | ₹25.41L |
| Interest Income Non Operating | ₹51.25L | ₹359.45L | ₹40.79L | ₹30.17L |
| Selling And Marketing Expense | ₹51.71L | ₹194.22L | ₹111.38L | ₹65.95L |
| Interest Expense Non Operating | ₹556.08L | ₹504.13L | ₹592.94L | ₹491.89L |
| Net Income Common Stockholders | ₹3,016.64L | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L |
| Net Income Continuous Operations | ₹2,950.03L | ₹2,494.01L | ₹1,357.52L | ₹828.27L |
| Diluted NIAvailto Com Stockholders | ₹3,016.64L | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L |
| General And Administrative Expense | ₹514.32L | ₹301.92L | ₹375.91L | ₹199.01L |
| Selling General And Administration | ₹566.03L | ₹496.14L | ₹487.29L | ₹264.96L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹362.25L | ₹395.99L | ₹138.85L | ₹81.82L |
| Net Non Operating Interest Income Expense | -₹578.11L | -₹172.57L | -₹562.85L | -₹478.12L |
| Net Income Including Noncontrolling Interests | ₹2,950.03L | ₹2,494.01L | ₹1,357.52L | ₹828.27L |
| Net Income From Continuing And Discontinued Operation | ₹3,016.64L | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L |
| Net Income From Continuing Operation Net Minority Interest | ₹3,016.64L | ₹2,670.06L | ₹1,460.14L | ₹1,044.81L |
Company Performance (FY23–FY26)
₹235.3 Cr₹176.5 Cr₹117.7 Cr₹58.8 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 12/05/1992 | Mukund Prataprai Mehta | 00147876 | Managing Director | View other directorships |
| 29/09/2007 | Bhavin Mukund Mehta | 00147895 | Whole-time director | View other directorships |
| 30/09/2014 | Mira Bhavin Mehta | 01902831 | Managing Director | View other directorships |
| 01/04/2015 | Hemang Jagadish Engineer | 02317989 | Director | View other directorships |
| 16/03/2018 | Vasudev Krishnamurti | 00567672 | Director | View other directorships |
| 28/06/2018 | Venkita Subramanian Rajan | 00059146 | Director | View other directorships |
| 01/03/2021 | Sunil Sureshji Jain | *****8872E | CFO | |
| 05/05/2022 | Pushpa Nyoupane | *****8988L | Company Secretary | |
| 27/08/2024 | Dipen Jayantilal Jain | 01148262 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 9
- Mira Bhavin MehtaManaging Director
- Mukund Prataprai MehtaManaging Director
- Bhavin Mukund MehtaWhole-time director
- Dipen Jayantilal JainDirector
- Venkita Subramanian RajanDirector
- Vasudev KrishnamurtiDirector
- Hemang Jagadish EngineerDirector
- Pushpa NyoupaneCompany Secretary
- Sunil Sureshji JainCFO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 11/12/2024 | Form AOC-4(XBRL)-11122024-signed | - |
| 25/11/2024 | Form MGT-7-25112024_signed | - |
| 17/02/2024 | Form Addendum to AOC-4 CSR-17022024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
C 301/2 Midc Ttc Indl Area Pawane, Thane, Thane, Maharashtra, India, 400705
Frequently Asked Questions
What is the incorporation date of Kilitch Drugs (india) Limited?
The incorporation date of Kilitch Drugs (india) Limited is 11/05/1992.
What is the authorized share capital and paid-up capital of Kilitch Drugs (india) Limited?
The authorized share capital of Kilitch Drugs (india) Limited is ₹25,00,00,000.00. The paid-up capital is ₹16,08,23,000.00.
Who are the current board members & directors of Kilitch Drugs (india) Limited?
The current board member of Kilitch Drugs (india) Limited are:
- Vasudev Krishnamurti
- Vasudev Krishnamurti
- Mukund Prataprai Mehta
- Bhavin Mukund Mehta
- Venkita Subramanian Rajan
- Mira Bhavin Mehta
- Hemang Jagadish Engineer
- Dipen Jayantilal Jain
What is the registered address of Kilitch Drugs (india) Limited?
The registered address of Kilitch Drugs (india) Limited is C 301/2 Midc Ttc Indl Area Pawane, Thane, Thane, Maharashtra, India, 400705.
What is the Corporate Identification Number of Kilitch Drugs (india) Limited?
The Corporate Identification Number of Kilitch Drugs (india) Limited is L24239MH1992PLC066718.